Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,477 total articles
Alphabet is trading at $344 with a $4.21 trillion market cap. YouTube - part of Google Services - is driving structural ad revenue gains, creator monetization, and AI data advantages that justify a measured long. Trade plan: enter $344.00, stop $320.00, target $420.00 over a long-term window (180 trading days).
Timken has rallied but fundamentals still back further upside. Buy a measured pullback to $125, stop $119, target the 52-week high at $146.37 with a secondary target at $160. Trade horizon: mid term (45 trading days).
Broadcom's mix of semiconductor solutions and infrastructure software leaves it uniquely positioned to benefit from hyperscaler XPU builds and the optics/networking shift inside AI data centers. Financials show robust cash generation (free cash flow $32.8B) and an EPS base ($6.16) that recent results suggest can re-rate into faster growth. The stoc…
Trupanion has finally returned to GAAP profitability and continues to scale claims and subscription volume, but the share price already prices in flawless execution. With a market cap near $1.65B, a P/E around 57 and EV/EBITDA ~32, I view the stock as too expensive for a fresh long. This piece lays out a tactical short trade over the next ~45 tradi…
Intuitive Machines (LUNR) is trading on optimism tied to a $1.1B backlog, fresh NASA award news, and accelerating revenue, yet capital raises and negative free cash flow remain real drags. This trade targets a controlled long entry on a pullback to $16.00 with a $30.00 target over a mid-term window (45 trading days) and a $13.50 stop. The plan bala…
PSH (PGIM Short Duration High Yield ETF) sits at the intersection of attractive cash yield and low duration risk. With a 30-day SEC yield of 5.27% and a distribution yield near 5.95%, PSH is a practical vehicle to pick up carry while limiting rate-volatility exposure. Technicals show mild bullish momentum and a clear upside target at the 52-week hi…
U.S. Gold Corp. (USAU) is trading well below a feasibility-study implied valuation despite strong project economics, ample cash and clear catalysts in 2026. The market appears to be penalizing the stock for execution risk; this trade targets that gap with a mid-term long plan, defined entry, stop and target and a balanced risk framework.
Ultragenyx (RARE) is trading well below its 52-week high after clinical setbacks and legal headlines. The company’s commercial franchise (Crysvita, Mepsevii, Dojolvi, Evkeeza) produces recurring revenue, its balance sheet shows operational leverage, and current market pricing (~$2.8B market cap) underestimates binary upside from two upcoming FDA de…
Alamar (ALMR) is executing a classic instrument-plus-consumables model with a twist: it is building an open, research-grade proteomics dataset that can accelerate demand for its NULISA assays and ARGO instruments. The stock trades like a high-growth research name; the trade here is to buy into momentum and the expanding data moat while protecting c…
Everspin Technologies (MRAM) is a small-cap MRAM specialist that has traded up sharply on AI/edge narratives. Fundamentals show modest revenue and negative EPS, but balance-sheet strength, a $40M defense contract and improving margins make a structured long worth considering. This trade idea outlines an entry at $16.80, stop at $12.50 and target at…
NextEra is capturing AI-driven data center demand while leaning on a regulated utility base (FPL) and a massive renewable pipeline. With market cap near $179B, a PE of ~19x and a $0.6232 quarterly dividend, the setup favors a long trade sized with a disciplined stop as the company converts large-load interest into contracted revenue.
Velo3D's top-line and margin momentum is real: Q1 2026 revenue grew 48% YoY to $13.8M, gross margin expanded to 17.2%, management is guiding $60-70M for FY2026 and expects positive EBITDA in H2 2026. Given recent commercial validation from SpaceX and improving technicals, I am upgrading VELO to Buy with a long-term trade plan. The trade carries exe…
Gencor reported stronger margins and a materially larger backlog that triggered a clean re-rating. The market has pushed the stock to new highs and key technicals look extended. We’re moving to Hold: stay patient, trim into strength, or take a tactical mid-term swing if you want exposure with a strict stop.
Blue Bird (BLBD) looks like a rare combination of quality operating returns and cheap valuation. Solid ROE (43%), meaningful free cash flow ($153M trailing), and a sub-8x P/E are flashing value while electric bus demand and policy support provide a multi-year growth backdrop. The trade below is a long-term (180 trading days) plan to capture multipl…
H.B. Fuller (FUL) is a diversified adhesives specialist whose mixed portfolio and solid cash generation create a fertile backdrop for a mid-term swing trade. At $60.15 the stock is trading below its 52-week high but shows reasonable valuation metrics (PE ~17.9, EV/EBITDA ~9.2) and constructive technicals. We propose a defined long with a $68.63 tar…
Lithium Americas (LAC) trades like a beaten-up project developer while carrying substantial optionality from the Thacker Pass asset and recent U.S. government support. At $3.43 the risk/reward favors a speculative long over a mid-term (45 trading days) horizon if catalysts like funding milestones or permitting progress show up. This trade is high-r…
TRX Gold is trading around $1.05 with a market cap of roughly $476M. The company reported fiscal 2025 revenue of $57.6M and EBITDA of $22M and is advancing its Buckreef Gold Project with a PEA showing ~62,000 oz/year production. With gold still well above long-term averages and a clear list of catalysts through 2028, we view the stock as fairly pri…
Huntsman is trading well below its 52-week high on merger-related uncertainty, but the deal with Olin, identified synergy targets of $300M+, and a modest balance sheet create a path for free cash flow inflection. The combination of valuation support (price-to-book ~0.66, market cap ~$1.83B) and a 3-4% run-rate dividend creates an asymmetric risk/re…
Microsoft has moved beyond the skeptics' debate and into a clear growth phase driven by Azure, AI partnerships, and sticky enterprise revenue. Fundamentals - strong free cash flow, double-digit margins, and a fortress balance sheet - back a lean long trade. I lay out a concrete entry, stop, targets, catalysts, and the risks that would force me to f…
Centrus (LEU) is the only U.S. company licensed to produce HALEU fuel and today’s price action looks constructive. With a $3.8B market cap, a multi-billion backlog, and a sizable DOE contract, Centrus has both government and commercial demand pulling in the same direction. This trade idea lays out a mid-term long: entry at $192.50, stop at $170.00,…
CNIKF trades at $1.10 with constructive momentum and an outsized short position (3.94M shares, 53.3 days to cover on 07/31/2026). That combination can spark sharp rallies if a financing or positive drill update lands — but the company’s OTC status, lack of public market cap/shares disclosure, and signs of thin liquidity mean financing will probably…
Amazon reported another quarter that underlines AWS-led operating leverage and hyperscaler AI spend, prompting a revised fair value and a tactical long trade. The setup balances near-term capex-driven cash flow pressure against accelerating cloud revenue and advertising strength. Entry $265.24, target $320.00, stop $240.00; horizon: long term (180 …
Immunome (IMNM) is a clinical-stage oncology-focused antibody developer trading at $26.42 with a market cap near $3.65B. With a planned NDA submission for varegacestat and an active analyst re-rate cycle, the stock offers a high-upside, binary setup. I maintain a Strong Buy and outline an actionable swing trade with clear entry, stop and target, wh…
DoubleDown Interactive (DDI) is trading at roughly $650.7M market cap, a P/E of ~4.85 and a PB of 0.60. Recent acquisition activity, an improving technical backdrop and what looks like attractive earnings power make it a compelling tactical long. This trade lays out entry, stop and targets with time horizons and the risks to watch.
Ashland (ASH) has been in the activist spotlight since Ancora’s presentation and the board’s public engagement. The stock is trading well above its 50-day average and shows bullish technical momentum while fundamentals - including $237M in free cash flow and a $0.42 quarterly dividend - give the company optionality on buybacks, divestitures or acce…
